false 2020-09-30 2020 Q3 0001778016--12-31 0001778016 2020-01-01 2020-09-30 0001778016 2019-12-31 0001778016 2020-09-30 0001778016 2019-01-01 2019-09-30 0001778016 2019-12-25 2019-12-25 0001778016 2019-01-01 2019-12-31 0001778016 2016-10-31 0001778016 2017-12-31 0001778016 2018-12-31 0001778016 2019-01-01 0001778016 2020-04-30 2020-04-30 0001778016 2020-02-10 2020-02-10 0001778016 2019-09-30 0001778016 imab:SeriesC1ConvertiblePreferredStockMember 2019-12-31 0001778016 imab:SeriesCConvertiblePreferredSharesMember 2019-12-31 0001778016 imab:SeriesBConvertiblePreferredSharesMember 2019-12-31 0001778016 imab:SeriesAConvertiblePreferredSharesMember 2019-12-31 0001778016 imab:LaboratoryEquipmentMember 2019-12-31 0001778016 us-gaap:LeaseholdImprovementsMember 2019-12-31 0001778016 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2019-12-31 0001778016 us-gaap:OfficeEquipmentMember 2019-12-31 0001778016 us-gaap:InProcessResearchAndDevelopmentMember 2019-12-31 0001778016 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001778016 us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001778016 imab:PeoplesBankOfChinaMember 2019-12-31 0001778016 imab:TwentyEighteenEmployeeStockOptionPlanMember 2019-12-31 0001778016 imab:TwentyNineteenShareIncentivePlanMember 2019-12-31 0001778016 imab:EverestMember 2019-12-31 0001778016 imab:TwentySeventeenEmployeeStockOptionPlanMember 2019-12-31 0001778016 imab:ImabHangzhouMember 2019-12-31 0001778016 imab:IMabBiopharmaHongKongLimitedMember 2020-09-30 0001778016 imab:IMabShanghaiMember 2020-09-30 0001778016 imab:IMabtianjinMember 2020-09-30 0001778016 imab:ImabbiopharmaUsLtdMember 2020-09-30 0001778016 imab:LaboratoryEquipmentMember 2020-09-30 0001778016 us-gaap:LeaseholdImprovementsMember 2020-09-30 0001778016 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2020-09-30 0001778016 us-gaap:OfficeEquipmentMember 2020-09-30 0001778016 us-gaap:InProcessResearchAndDevelopmentMember 2020-09-30 0001778016 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2020-09-30 0001778016 us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0001778016 imab:PeoplesBankOfChinaMember 2020-09-30 0001778016 imab:FederalReserveBankOfNewYorkMember 2020-09-30 0001778016 imab:SeriesBConvertiblePreferredSharesMember 2020-09-30 0001778016 imab:SeriesAConvertiblePreferredSharesMember 2020-09-30 0001778016 imab:SeriesCConvertiblePreferredSharesMember 2020-09-30 0001778016 imab:SeriesC1ConvertiblePreferredStockMember 2020-09-30 0001778016 imab:ShareIncentivePlanTwoThousandTwentyMember 2020-09-30 0001778016 imab:OutLicensingAgreementsMember imab:EverestMember 2020-09-30 0001778016 imab:TwentyNineteenEmployeeStockOptionPlanMember 2020-09-30 0001778016 imab:EverestMember 2020-09-30 0001778016 imab:AmericanDepositarySharesMember us-gaap:PrivatePlacementMember 2020-09-30 0001778016 imab:AmericanDepositarySharesMember imab:InvestorWarrantsMember 2020-09-30 0001778016 imab:TwentySeventeenEmployeeStockOptionPlanMember 2020-09-30 0001778016 imab:Shareincentiveplan2020memberMember 2020-09-30 0001778016 imab:ImabHangzhouMember 2020-09-30 0001778016 imab:ManagementHoldcoMember imab:ImabHangzhouMember 2020-09-30 0001778016 imab:ImabHangzhouMember imab:EsopHoldcoMember 2020-09-30 0001778016 imab:ImabHangzhouMember imab:DomesticInvestorsMember 2020-09-30 0001778016 imab:ImabHongKongMember 2020-09-30 0001778016 imab:DomesticInvestorsMember 2020-09-30 0001778016 imab:EsopHoldcoMember 2020-09-30 0001778016 imab:ManagementHoldcoMember 2020-09-30 0001778016 imab:BoardOfDirectorsMember imab:AmericanDepositarySharesMember 2020-09-30 0001778016 imab:HillhouseEntitiesMember imab:FirstClosingPeriodMember 2020-09-30 0001778016 imab:TwentyseventeenEmployeeStockOptionPlanMember 2020-09-30 0001778016 imab:InvestorWarrantsMember 2020-09-30 0001778016 imab:WarrantsToPurchaseOrdinarySharesMember 2020-09-30 0001778016 imab:TwentyEighteenEmployeeStockOptionPlanMember 2020-09-30 0001778016 us-gaap:RetainedEarningsMember 2019-01-01 2019-09-30 0001778016 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-09-30 0001778016 us-gaap:ConvertiblePreferredStockMember 2019-01-01 2019-09-30 0001778016 us-gaap:RestrictedStockMember 2019-01-01 2019-09-30 0001778016 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-09-30 0001778016 imab:SeriesAConvertiblePreferredStockMember 2019-01-01 2019-09-30 0001778016 imab:SeriesBConvertiblePreferredStockMember 2019-01-01 2019-09-30 0001778016 imab:SeriesCConvertiblePreferredStockMember 2019-01-01 2019-09-30 0001778016 imab:SeriesC1ConvertiblePreferredStockMember 2019-01-01 2019-09-30 0001778016 us-gaap:ResearchAndDevelopmentExpenseMember 2019-01-01 2019-09-30 0001778016 us-gaap:GeneralAndAdministrativeExpenseMember 2019-01-01 2019-09-30 0001778016 us-gaap:RestrictedStockMember us-gaap:ResearchAndDevelopmentExpenseMember 2019-01-01 2019-09-30 0001778016 us-gaap:RestrictedStockMember us-gaap:GeneralAndAdministrativeExpenseMember 2019-01-01 2019-09-30 0001778016 us-gaap:RestrictedStockMember 2019-01-01 2019-09-30 0001778016 imab:LicensingAgreementWithABLBioMember 2019-01-01 2019-09-30 0001778016 imab:CollaborationAgreementWithABLBioMember 2019-01-01 2019-09-30 0001778016 imab:ABLBioMember imab:LicensingAgreementWithABLBioMember us-gaap:OperatingExpenseMember 2019-01-01 2019-09-30 0001778016 imab:CollaborationAgreementWithABLBioMember us-gaap:OperatingExpenseMember 2019-01-01 2019-09-30 0001778016 imab:CollaborationAgreementWithABLBioMember us-gaap:OperatingExpenseMember imab:ABLBioMember 2019-01-01 2019-09-30 0001778016 imab:CollaborationAgreementsWithTraconPharmaceuticalsIncMember us-gaap:OperatingExpenseMember 2019-01-01 2019-09-30 0001778016 us-gaap:EmployeeStockOptionMember srt:DirectorMember us-gaap:GeneralAndAdministrativeExpenseMember 2019-01-01 2019-09-30 0001778016 imab:TaslyPharmaceuticalGroupCoLtdMember imab:ReceiptOfContractResearchOrganizationsMember 2019-01-01 2019-09-30 0001778016 imab:CmabBiopharmaSuzhouIncMember imab:ProjectDevelopmentFeeMember 2019-01-01 2019-09-30 0001778016 imab:EverestMember 2019-01-01 2019-09-30 0001778016 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-09-30 0001778016 us-gaap:RetainedEarningsMember 2020-01-01 2020-09-30 0001778016 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-09-30 0001778016 imab:IMabBiopharmaHongKongLimitedMember 2020-01-01 2020-09-30 0001778016 imab:IMabShanghaiMember 2020-01-01 2020-09-30 0001778016 imab:IMabtianjinMember 2020-01-01 2020-09-30 0001778016 imab:ImabbiopharmaUsLtdMember 2020-01-01 2020-09-30 0001778016 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-09-30 0001778016 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-09-30 0001778016 us-gaap:ConvertiblePreferredStockMember 2020-01-01 2020-09-30 0001778016 us-gaap:ShortTermInvestmentsMember 2020-01-01 2020-09-30 0001778016 imab:PutRightLiabilitiesMember 2020-01-01 2020-09-30 0001778016 imab:LaboratoryEquipmentMember srt:MinimumMember 2020-01-01 2020-09-30 0001778016 imab:LaboratoryEquipmentMember srt:MaximumMember 2020-01-01 2020-09-30 0001778016 imab:SoftwareMember srt:MinimumMember 2020-01-01 2020-09-30 0001778016 imab:SoftwareMember srt:MaximumMember 2020-01-01 2020-09-30 0001778016 imab:OfficeFurnitureAndEquipmentMember 2020-01-01 2020-09-30 0001778016 srt:MinimumMember 2020-01-01 2020-09-30 0001778016 srt:MaximumMember 2020-01-01 2020-09-30 0001778016 imab:SeriesB2PreferredSharesMember 2020-01-01 2020-09-30 0001778016 imab:AmericanDepositarySharesMember imab:InvestorWarrantsMember 2020-01-01 2020-09-30 0001778016 imab:TrancheIOfSeriesBWarrantsMember 2020-01-01 2020-09-30 0001778016 imab:TrancheIiOfSeriesBWarrantsMember 2020-01-01 2020-09-30 0001778016 us-gaap:RestrictedStockMember 2020-01-01 2020-09-30 0001778016 imab:TwentyEighteenEmployeeStockOptionPlanMember 2020-01-01 2020-09-30 0001778016 imab:TwentyNineteenEmployeeStockOptionPlanMember 2020-01-01 2020-09-30 0001778016 imab:ShareIncentivePlanTwoThousandTwentyMember 2020-01-01 2020-09-30 0001778016 us-gaap:RestrictedStockMember imab:ShareIncentivePlanTwoThousandTwentyMember 2020-01-01 2020-09-30 0001778016 imab:TwentyEighteenEmployeeStockOptionPlanMember us-gaap:RestrictedStockMember 2020-01-01 2020-09-30 0001778016 us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-09-30 0001778016 us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-09-30 0001778016 us-gaap:RestrictedStockMember us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-09-30 0001778016 us-gaap:RestrictedStockMember us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-09-30 0001778016 imab:CspcMember imab:LicensingAgreementWithCSPCPharmaceuticalGroupLimitedMember 2020-01-01 2020-09-30 0001778016 imab:MorphosysMember imab:LicensingAgreementWithMorphosysAgMember 2020-01-01 2020-09-30 0001778016 us-gaap:ResearchAndDevelopmentExpenseMember imab:GenexineIncMember imab:LicensingAgreementWithGenexineIncMember 2020-01-01 2020-09-30 0001778016 imab:LicensingAgreementWithGenexineIncMember us-gaap:ResearchAndDevelopmentExpenseMember imab:GenexineIncMember 2020-01-01 2020-09-30 0001778016 imab:LicensingAgreementWithABLBioMember 2020-01-01 2020-09-30 0001778016 imab:LicensingAgreementWithGenexineIncMember imab:GenexineIncMember 2020-01-01 2020-09-30 0001778016 imab:LicensingAgreementWithGenexineIncMember imab:GenexineIncMember imab:Gxi7Member 2020-01-01 2020-09-30 0001778016 imab:OtherInLicensingAgreementsMember 2020-01-01 2020-09-30 0001778016 imab:OtherinlicensingarrangementsMember 2020-01-01 2020-09-30 0001778016 imab:LicensingAgreementWithMacrogenicsMember imab:MacroGenicsMember 2020-01-01 2020-09-30 0001778016 imab:OutLicensingAgreementsMember imab:EverestMember 2020-01-01 2020-09-30 0001778016 imab:LicensingAgreementWithABLBioMember us-gaap:OperatingExpenseMember imab:ABLBioMember 2020-01-01 2020-09-30 0001778016 imab:ABLBioMember us-gaap:OperatingExpenseMember imab:LicensingAgreementWithABLBioMember 2020-01-01 2020-09-30 0001778016 imab:CollaborationAgreementWithABLBioMember us-gaap:OperatingExpenseMember 2020-01-01 2020-09-30 0001778016 imab:CollaborationAgreementWithABLBioMember us-gaap:OperatingExpenseMember imab:ABLBioMember 2020-01-01 2020-09-30 0001778016 imab:CollaborationAgreementsWithTraconPharmaceuticalsIncMember us-gaap:OperatingExpenseMember 2020-01-01 2020-09-30 0001778016 imab:CollaborationAgreementWithABLBioMember 2020-01-01 2020-09-30 0001778016 imab:TwentySeventeenEmployeeStockOptionPlanMember 2020-01-01 2020-09-30 0001778016 imab:TwentySeventeenEmployeeStockOptionPlanMember us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-09-30 0001778016 imab:TwentySeventeenEmployeeStockOptionPlanMember us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-09-30 0001778016 imab:TwentySeventeenEmployeeStockOptionPlanMember us-gaap:EmployeeStockOptionMember 2020-01-01 2020-09-30 0001778016 imab:TwentyEighteenEmployeeStockOptionPlanMember us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-09-30 0001778016 imab:TwentyEighteenEmployeeStockOptionPlanMember us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-09-30 0001778016 imab:TwentyNineteenShareIncentivePlanMember 2020-01-01 2020-09-30 0001778016 imab:Shareincentiveplan2020memberMember 2020-01-01 2020-09-30 0001778016 imab:Shareincentiveplan2020memberMember us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-09-30 0001778016 imab:Shareincentiveplan2020memberMember us-gaap:RestrictedStockMember us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-09-30 0001778016 imab:Shareincentiveplan2020memberMember us-gaap:RestrictedStockMember us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-09-30 0001778016 imab:TwentyEighteenEmployeeStockOptionPlanMember us-gaap:EmployeeStockOptionMember us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-09-30 0001778016 imab:TwentyEighteenEmployeeStockOptionPlanMember us-gaap:EmployeeStockOptionMember us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-09-30 0001778016 us-gaap:LeaseholdImprovementsMember 2020-01-01 2020-09-30 0001778016 us-gaap:CommonStockMember 2020-01-01 2020-09-30 0001778016 imab:TaslyPharmaceuticalGroupCoLtdMember imab:ReceiptOfContractResearchOrganizationsMember 2020-01-01 2020-09-30 0001778016 imab:CmabBiopharmaSuzhouIncMember imab:ProjectDevelopmentFeeMember 2020-01-01 2020-09-30 0001778016 imab:EverestMember 2020-01-01 2020-09-30 0001778016 imab:HealSunMember imab:LicensingAgreementAmongHdymImabAndHangzhouHealsunBiopharmCoLtdMember 2020-01-01 2020-09-30 0001778016 imab:SeriesBWarrantsSharesMember 2020-01-01 2020-09-30 0001778016 imab:SeriesAConvertiblePreferredStockMember 2020-01-01 2020-09-30 0001778016 imab:SeriesBConvertiblePreferredStockMember 2020-01-01 2020-09-30 0001778016 imab:SeriesCConvertiblePreferredStockMember 2020-01-01 2020-09-30 0001778016 imab:SeriesC1ConvertiblePreferredStockMember 2020-01-01 2020-09-30 0001778016 imab:AmericanDepositarySharesMember us-gaap:PrivatePlacementMember 2020-01-01 2020-09-30 0001778016 imab:LicensingAgreementWithKgBioMember imab:KgBioMember 2020-01-01 2020-09-30 0001778016 us-gaap:GrantMember 2020-01-01 2020-09-30 0001778016 imab:ImabHangzhouMember imab:DomesticInvestorsMember 2020-01-01 2020-09-30 0001778016 imab:ImabHangzhouMember 2020-01-01 2020-09-30 0001778016 imab:ManagementHoldcoMember imab:ImabHangzhouMember 2020-01-01 2020-09-30 0001778016 imab:CollaborationAgreementWithInvestoresMember 2020-01-01 2020-09-30 0001778016 imab:HillhouseEntitiesMember imab:FirstClosingPeriodMember 2020-01-01 2020-09-30 0001778016 imab:HillhouseEntitiesMember 2020-01-01 2020-09-30 0001778016 imab:WarrantsToPurchaseOrdinarySharesMember 2020-01-01 2020-09-30 0001778016 imab:SpecialAwardMember imab:TwentyEighteenEmployeeStockOptionPlanMember 2020-01-01 2020-09-30 0001778016 imab:AbbvieMember 2020-01-01 2020-09-30 0001778016 imab:GenexineIncMember 2020-01-01 2020-09-30 0001778016 imab:GenexineIncMember us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-09-30 0001778016 imab:Shareincentiveplan2020memberMember us-gaap:RestrictedStockMember 2020-01-01 2020-09-30 0001778016 imab:TwentyEighteenEmployeeStockOptionPlanMember us-gaap:EmployeeStockOptionMember 2020-01-01 2020-09-30 0001778016 imab:LicensingAgreementWithMorphosysAgMember imab:MorphoSysAGMember us-gaap:ResearchAndDevelopmentExpenseMember 2018-01-01 2018-12-31 0001778016 imab:LicensingAgreementWithCSPCPharmaceuticalGroupLimitedMember imab:CspcMember 2018-01-01 2018-12-31 0001778016 us-gaap:ResearchAndDevelopmentExpenseMember imab:LicensingAgreementWithMorphosysAgMember imab:MorphosysMember 2018-01-01 2018-12-31 0001778016 imab:GenexineIncMember imab:LicensingAgreementWithGenexineIncMember 2018-01-01 2018-12-31 0001778016 imab:OutLicensingAgreementsMember imab:EverestMember 2018-01-01 2018-12-31 0001778016 imab:LicensingAgreementWithABLBioMember 2018-01-01 2018-12-31 0001778016 srt:MinimumMember 2019-01-01 2019-12-31 0001778016 srt:MaximumMember 2019-01-01 2019-12-31 0001778016 us-gaap:ResearchAndDevelopmentExpenseMember 2019-01-01 2019-12-31 0001778016 us-gaap:GeneralAndAdministrativeExpenseMember 2019-01-01 2019-12-31 0001778016 us-gaap:RestrictedStockMember us-gaap:ResearchAndDevelopmentExpenseMember 2019-01-01 2019-12-31 0001778016 us-gaap:RestrictedStockMember us-gaap:GeneralAndAdministrativeExpenseMember 2019-01-01 2019-12-31 0001778016 us-gaap:RestrictedStockMember 2019-01-01 2019-12-31 0001778016 imab:TwentyEighteenEmployeeStockOptionPlanMember 2019-01-01 2019-12-31 0001778016 imab:MacroGenicsMember us-gaap:LicensingAgreementsMember us-gaap:ResearchAndDevelopmentExpenseMember 2019-01-01 2019-12-31 0001778016 imab:OtherInLicensingAgreementsMember 2019-01-01 2019-12-31 0001778016 imab:LicensingAgreementWithMacrogenicsMember imab:MacroGenicsMember us-gaap:ResearchAndDevelopmentExpenseMember 2019-01-01 2019-12-31 0001778016 imab:LicensingAgreementWithMacrogenicsMember imab:MacroGenicsMember imab:DevelopmentMilestoneMember 2019-01-01 2019-12-31 0001778016 imab:MacroGenicsMember us-gaap:LicensingAgreementsMember us-gaap:ResearchAndDevelopmentExpenseMember srt:MinimumMember 2019-01-01 2019-12-31 0001778016 imab:LicensingAgreementWithMorphosysAgMember imab:MorphosysMember us-gaap:ResearchAndDevelopmentExpenseMember 2019-01-01 2019-12-31 0001778016 imab:LicensingAgreementWithGenexineIncMember us-gaap:ResearchAndDevelopmentExpenseMember imab:GenexineIncMember 2019-01-01 2019-12-31 0001778016 imab:LicensingAgreementWithGenexineIncMember imab:GenexineIncMember 2019-01-01 2019-12-31 0001778016 imab:CollaborationAgreementWithEverestMember imab:EverestMember 2019-01-01 2019-12-31 0001778016 imab:LicensingAgreementWithABLBioMember us-gaap:OperatingExpenseMember imab:ABLBioMember 2019-01-01 2019-12-31 0001778016 imab:CollaborationAgreementWithABLBioMember 2019-01-01 2019-12-31 0001778016 imab:CollaborationAgreementWithABLBioMember imab:ABLBioMember 2019-01-01 2019-12-31 0001778016 imab:CollaborationAgreementsWithTraconPharmaceuticalsIncMember us-gaap:OperatingExpenseMember 2019-01-01 2019-12-31 0001778016 imab:TwentySeventeenEmployeeStockOptionPlanMember 2019-01-01 2019-12-31 0001778016 imab:TwentyEighteenEmployeeStockOptionPlanMember us-gaap:GeneralAndAdministrativeExpenseMember 2019-01-01 2019-12-31 0001778016 imab:TwentySeventeenEmployeeStockOptionPlanMember us-gaap:EmployeeStockOptionMember 2019-01-01 2019-12-31 0001778016 imab:LicensingAgreementWithCSPCPharmaceuticalGroupLimitedMember imab:CspcMember 2019-01-01 2019-12-31 0001778016 imab:TasgenGroupMember 2017-07-15 0001778016 srt:DirectorMember 2019-10-29 0001778016 imab:SeriesA1AndA2PreferredStockMember 2016-10-18 2016-10-18 0001778016 imab:ConvertiblePreferredStockSeriesA3Member 2016-10-18 0001778016 imab:SeriesA1AndA2PreferredStockMember 2016-10-18 0001778016 imab:SeriesA3PreferredStockMember 2017-09-06 2017-09-06 0001778016 imab:SeriesA3PreferredStockMember 2017-09-06 0001778016 imab:SeriesBPreferredShareholdersMember 2017-09-22 2017-09-22 0001778016 imab:ConvertiblePreferredStockSeriesBMember 2017-09-22 2017-09-22 0001778016 imab:ConvertiblePreferredStockSeriesBMember 2017-09-22 0001778016 imab:ConvertiblePreferredStockSeriesB2Member 2017-09-22 0001778016 imab:SeriesB2PreferredSharesMember 2018-06-29 0001778016 imab:ConvertiblePreferredStockSeriesAThreeUponExerciseMember 2018-06-29 0001778016 imab:ConvertiblePreferredStockSeriesBOneUponConversionMember 2018-06-29 0001778016 imab:ConvertiblePreferredStockSeriesBTwoUponExerciseMember 2018-06-29 0001778016 imab:ConvertiblePreferredStockSeriesBUponExerciseMember 2018-06-29 0001778016 imab:ConvertiblePreferredStockSeriesBOneUponExerciseMember 2018-06-29 0001778016 imab:TrancheIOfSeriesBWarrantsMember 2018-07-06 0001778016 imab:SeriesBWarrantsSharesMember 2018-07-06 0001778016 us-gaap:SeriesCPreferredStockMember 2018-07-06 0001778016 imab:ConvertiblePreferredStockSeriesBUponExerciseMember 2018-07-06 0001778016 imab:ConvertiblePreferredStockSeriesBOneUponExerciseMember 2018-07-06 0001778016 imab:ConvertiblePreferredStockSeriesBTwoUponExerciseMember 2018-07-06 0001778016 us-gaap:SeriesCPreferredStockMember 2018-07-06 2018-07-06 0001778016 imab:SeriesCOnePreferredStockMember 2019-07-25 0001778016 imab:SeriesCOneConvertiblePreferredStockMember 2019-10-17 2019-10-17 0001778016 imab:SeriesCOneConvertiblePreferredStockMember 2019-10-17 0001778016 imab:SeriesCOneConvertiblePreferredStockMember 2019-11-06 2019-11-06 0001778016 imab:SeriesCOnePreferredStockMember 2019-11-06 2019-11-06 0001778016 imab:SeriesCOneConvertiblePreferredStockMember 2019-11-06 0001778016 imab:SeriesCOnePreferredStockMember 2019-12-25 2019-12-25 0001778016 srt:MinimumMember 2019-12-25 0001778016 srt:MaximumMember 2019-12-25 0001778016 imab:TemporaryEquityMember us-gaap:PreferredStockMember 2019-01-25 2019-12-25 0001778016 imab:SeriesBOnshoreInvestorsMember 2017-09-25 2017-09-25 0001778016 imab:SeriesB2PreferredSharesMember 2018-06-29 2018-07-06 0001778016 us-gaap:MeasurementInputRiskFreeInterestRateMember 2020-09-11 0001778016 us-gaap:MeasurementInputPriceVolatilityMember 2020-09-11 0001778016 us-gaap:MeasurementInputExercisePriceMember 2020-09-11 0001778016 us-gaap:MeasurementInputMaturityMember 2020-09-11 0001778016 imab:FoundersMember 2016-01-01 2016-12-31 0001778016 imab:ThirdVentureMember 2016-01-01 2016-12-31 0001778016 imab:FoundersMember us-gaap:RestrictedStockMember 2016-06-01 2016-06-30 0001778016 us-gaap:RestrictedStockMember imab:FoundersMember 2016-10-01 2016-10-31 0001778016 imab:FoundersMember us-gaap:RestrictedStockMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2016-10-01 2016-10-31 0001778016 imab:FoundersMember us-gaap:RestrictedStockMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2016-10-01 2016-10-31 0001778016 imab:FoundersMember us-gaap:RestrictedStockMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2016-10-01 2016-10-31 0001778016 imab:FoundersMember us-gaap:RestrictedStockMember 2016-10-31 0001778016 us-gaap:RestrictedStockMember imab:FoundersMember 2019-10-31 2019-10-31 0001778016 imab:TwentySeventeenEmployeeStockOptionPlanMember us-gaap:EmployeeStockOptionMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2017-10-01 2017-10-31 0001778016 us-gaap:ShareBasedCompensationAwardTrancheThreeMember us-gaap:EmployeeStockOptionMember imab:TwentySeventeenEmployeeStockOptionPlanMember 2017-10-01 2017-10-31 0001778016 imab:Shareincentiveplan2020memberMember us-gaap:EmployeeStockOptionMember 2017-10-01 2017-10-31 0001778016 imab:TwentySeventeenEmployeeStockOptionPlanMember 2017-10-31 0001778016 imab:MorphosysMember imab:LicensingAgreementWithMorphosysAgMember us-gaap:ResearchAndDevelopmentExpenseMember 2017-01-01 2017-12-31 0001778016 imab:LeiFangMember us-gaap:EmployeeStockOptionMember 2017-01-01 2017-12-31 0001778016 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-12-31 0001778016 us-gaap:IPOMember imab:AmericanDepositarySharesMember 2020-01-31 2020-01-31 0001778016 imab:TwentyEighteenEmployeeStockOptionPlanMember 2020-01-17 2020-01-17 0001778016 imab:TwentySeventeenEmployeeStockOptionPlanMember 2020-01-17 2020-01-17 0001778016 imab:ConvertiblePreferredStockSeriesBMember 2020-01-17 2020-01-17 0001778016 imab:ConvertiblePreferredStockSeriesBOneUponConversionMember 2020-01-17 2020-01-17 0001778016 imab:ConvertiblePreferredStockSeriesB2Member 2020-01-17 2020-01-17 0001778016 us-gaap:SeriesCPreferredStockMember 2020-01-17 2020-01-17 0001778016 imab:SeriesCOneConvertiblePreferredStockMember 2020-01-17 2020-01-17 0001778016 imab:SeriesAConvertiblePreferredStockMember 2020-01-17 2020-01-17 0001778016 imab:SeriesAConvertiblePreferredSharesMember 2020-01-17 2020-01-17 0001778016 imab:SeriesBConvertiblePreferredSharesMember 2020-01-17 2020-01-17 0001778016 imab:ConvertiblePreferredStockSeriesBTwoUponExerciseMember 2020-01-17 2020-01-17 0001778016 imab:SeriesCOnePreferredStockMember 2020-01-17 2020-01-17 0001778016 imab:SeniorManagementEmployeesMember imab:TwentyEighteenEmployeeStockOptionPlanMember 2020-01-17 2020-01-17 0001778016 imab:TwentySeventeenEmployeeStockOptionPlanMember imab:SeniorManagementEmployeesMember 2020-01-17 2020-01-17 0001778016 imab:TwentySeventeenEmployeeStockOptionPlanMember 2020-01-17 0001778016 imab:AmericanDepositarySharesMember us-gaap:IPOMember 2020-01-17 0001778016 imab:CollaborationAgreementWithEverestMember imab:EverestMember 2020-01-17 0001778016 imab:SeriesAConvertiblePreferredStockMember 2020-01-17 0001778016 imab:ConvertiblePreferredStockSeriesBMember 2020-01-17 0001778016 imab:ConvertiblePreferredStockSeriesBOneUponConversionMember 2020-01-17 0001778016 imab:ConvertiblePreferredStockSeriesB2Member 2020-01-17 0001778016 us-gaap:SeriesCPreferredStockMember 2020-01-17 0001778016 imab:SeriesCOneConvertiblePreferredStockMember 2020-01-17 0001778016 imab:SeriesAConvertiblePreferredSharesMember 2020-01-17 0001778016 imab:SeriesBConvertiblePreferredSharesMember 2020-01-17 0001778016 imab:ConvertiblePreferredStockSeriesBTwoUponExerciseMember 2020-01-17 0001778016 imab:AmericanDepositarySharesMember us-gaap:OverAllotmentOptionMember 2020-02-10 2020-02-10 0001778016 imab:AmericanDepositarySharesMember us-gaap:OverAllotmentOptionMember 2020-02-10 0001778016 imab:ChinaMerchantBankCoLtdMember imab:LoanOneMember 2019-06-30 0001778016 imab:ChinaMerchantBankCoLtdMember imab:LoanOneMember 2019-06-01 2019-06-30 0001778016 imab:Shareincentiveplan2020memberMember 2020-07-15 0001778016 us-gaap:RestrictedStockMember 2020-07-15 0001778016 imab:AmericanDepositarySharesMember imab:BoardOfDirectorsMember 2020-07-15 0001778016 imab:GenexineIncMember imab:TwoZeroOneEightNotesMember 2020-12-31 0001778016 imab:TwoZeroOneEightNotesMember us-gaap:SubsequentEventMember imab:GenexineIncMember 2020-12-31 0001778016 imab:SecondClosingPeriodMember imab:HillhouseEntitiesMember 2020-12-31 0001778016 imab:AbbvieMember us-gaap:SubsequentEventMember 2020-12-31 0001778016 imab:MorphoSysAGMember imab:LicensingAgreementWithMorphosysAgMember us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-12-31 0001778016 imab:LicensingAgreementWithABLBioMember 2020-01-01 2020-12-31 0001778016 imab:LicensingAgreementWithGenexineIncMember imab:GenexineIncMember us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-12-31 0001778016 imab:ABLBioMember imab:LicensingAgreementWithABLBioMember us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-12-31 0001778016 imab:SeriesBWarrantsSharesMember 2020-01-01 2020-12-31 0001778016 imab:SecondClosingPeriodMember imab:HillhouseEntitiesMember 2020-01-01 2020-12-31 0001778016 imab:ConvertiblePromissoryNotes2018Member imab:SeriesB1PreferredSharesMember 2018-02-03 0001778016 imab:ConvertiblePromissoryNotes2018Member imab:SeriesA3PreferredSharesMember 2018-02-03 0001778016 imab:TwoZeroOneEightNotesMember imab:SeriesA3PreferredSharesMember 2018-02-03 2018-02-03 0001778016 imab:ConvertiblePromissoryNotes2018Member imab:SeriesA3PreferredSharesMember 2018-02-03 2018-02-03 0001778016 imab:ImabHangzhouMember 2020-07-31 0001778016 imab:ImabHangzhouMember 2019-07-31 0001778016 imab:AmendmentSubscriptionAgreementWithHillHouseEntitiesMember 2020-12-01 2020-12-31 0001778016 imab:TwoZeroOneEightNotesMember imab:GenexineIncMember us-gaap:SubsequentEventMember 2020-12-01 2020-12-31 0001778016 imab:AbbvieMember us-gaap:SubsequentEventMember 2020-12-01 2020-12-31 0001778016 imab:LicensingAgreementWithABLBioMember imab:ABLBioMember 2020-01-01 2020-01-31 0001778016 imab:LicensingAgreementWithABLBioMember imab:ABLBioMember imab:SalesMilestonesMember 2020-01-01 2020-01-31 0001778016 imab:LicensingAgreementWithABLBioMember imab:ABLBioMember 2020-01-01 2020-01-31 0001778016 imab:LicensingAgreementWithABLBioMember imab:ABLBioMember imab:ClinicalMilestonesMember 2020-01-01 2020-01-31 0001778016 imab:AbbvieMember 2020-09-03 2020-09-03 0001778016 imab:AbbvieMember imab:ClinicalMilestonesMember 2020-09-03 2020-09-03 0001778016 imab:AbbvieMember srt:MinimumMember 2020-09-03 2020-09-03 0001778016 imab:AbbvieMember srt:MaximumMember 2020-09-03 2020-09-03 0001778016 imab:LicensingAgreementWithMorphosyMember imab:MorphoSysAGMember 2017-11-17 2017-11-17 0001778016 imab:LicensingAgreementWithGenexineIncMember imab:GenexineIncMember 2018-01-01 2018-01-01 0001778016 imab:OutLicensingAgreementsMember imab:EverestMember 2019-11-04 0001778016 imab:LicensingAgreementWithCSPCPharmaceuticalGroupLimitedMember imab:CspcMember 2019-02-28 2019-02-28 0001778016 imab:LicensingAgreementWithCSPCPharmaceuticalGroupLimitedMember imab:CspcMember 2018-12-31 0001778016 imab:EverestMember imab:CollaborationAgreementWithEverestMember 2020-01-31 0001778016 imab:MorphoSysAGMember imab:LicensingAgreementWithMorphosysAgMember 2020-08-01 2020-08-31 0001778016 imab:ImabHangzhouMember 2019-06-16 0001778016 imab:AmericanDepositarySharesMember us-gaap:IPOMember 2020-01-17 2020-01-31 0001778016 imab:TwentyEighteenEmployeeStockOptionPlanMember 2019-02-22 0001778016 imab:TwentyEighteenEmployeeStockOptionPlanMember srt:DirectorMember 2019-02-22 0001778016 imab:AmendedTwentySeventeenEmployeeStockOptionPlanMember srt:DirectorMember 2019-02-22 0001778016 imab:TwentyEighteenEmployeeStockOptionPlanMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2019-02-22 2019-02-22 0001778016 imab:TwentyEighteenEmployeeStockOptionPlanMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2019-02-22 2019-02-22 0001778016 imab:Shareincentiveplan2020memberMember us-gaap:EmployeeStockOptionMember 2019-02-22 2019-02-22 0001778016 imab:DrzangMember imab:TwentyEighteenEmployeeStockOptionPlanMember 2019-02-22 2019-02-22 0001778016 imab:AmendedTwentySeventeenEmployeeStockOptionPlanMember srt:DirectorMember 2019-02-22 2019-02-22 0001778016 srt:DirectorMember 2019-02-22 2019-02-22 0001778016 imab:Shareincentiveplan2020memberMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2020-07-15 2020-09-30 0001778016 imab:Shareincentiveplan2020memberMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2020-07-15 2020-09-30 0001778016 imab:Shareincentiveplan2020memberMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2020-07-15 2020-09-30 0001778016 imab:Shareincentiveplan2020memberMember imab:ShareBasedCompensationTrancheFourMember 2020-07-15 2020-09-30 0001778016 imab:ThirdOneThirdPortionMember us-gaap:RestrictedStockMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2020-07-15 2020-09-30 0001778016 imab:ThirdOneThirdPortionMember us-gaap:RestrictedStockMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2020-07-15 2020-09-30 0001778016 imab:ThirdOneThirdPortionMember us-gaap:RestrictedStockMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2020-07-15 2020-09-30 0001778016 imab:ThirdOneThirdPortionMember us-gaap:RestrictedStockMember imab:ShareBasedCompensationTrancheFourMember 2020-07-15 2020-09-30 0001778016 imab:ThirdOneThirdPortionMember us-gaap:RestrictedStockMember imab:OnePerformanceConditionMember 2020-07-15 2020-09-30 0001778016 imab:ThirdOneThirdPortionMember us-gaap:RestrictedStockMember imab:TwoPerformanceConditionsMember 2020-07-15 2020-09-30 0001778016 imab:ThirdOneThirdPortionMember us-gaap:RestrictedStockMember imab:ThreePerformanceConditionsMember 2020-07-15 2020-09-30 0001778016 imab:ThirdOneThirdPortionMember us-gaap:RestrictedStockMember imab:FourPerformanceConditionsMember 2020-07-15 2020-09-30 0001778016 imab:ThirdOneThirdPortionMember us-gaap:RestrictedStockMember imab:Shareincentiveplan2020memberMember 2020-07-15 2020-09-30 0001778016 imab:SecondOneThirdPortionMember us-gaap:RestrictedStockMember imab:Shareincentiveplan2020memberMember 2020-07-15 2020-09-30 0001778016 us-gaap:RetainedEarningsMember 2018-12-31 0001778016 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001778016 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001778016 us-gaap:TreasuryStockMember 2018-12-31 0001778016 us-gaap:CommonStockMember 2018-12-31 0001778016 imab:SeriesAConvertiblePreferredStockMember 2018-12-31 0001778016 imab:SeriesBConvertiblePreferredStockMember 2018-12-31 0001778016 imab:SeriesCConvertiblePreferredStockMember 2018-12-31 0001778016 imab:SeriesC1ConvertiblePreferredStockMember 2018-12-31 0001778016 imab:SeriesAConvertiblePreferredStockMember 2019-09-30 0001778016 imab:SeriesBConvertiblePreferredStockMember 2019-09-30 0001778016 imab:SeriesCConvertiblePreferredStockMember 2019-09-30 0001778016 imab:SeriesC1ConvertiblePreferredStockMember 2019-09-30 0001778016 us-gaap:CommonStockMember 2019-09-30 0001778016 us-gaap:TreasuryStockMember 2019-09-30 0001778016 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0001778016 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-30 0001778016 us-gaap:RetainedEarningsMember 2019-09-30 0001778016 us-gaap:RetainedEarningsMember 2019-12-31 0001778016 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001778016 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001778016 us-gaap:CommonStockMember 2019-12-31 0001778016 us-gaap:ShortTermInvestmentsMember 2019-12-31 0001778016 imab:PutRightLiabilitiesMember 2019-12-31 0001778016 imab:SeriesCConvertiblePreferredStockMember 2019-12-31 0001778016 imab:SeriesBConvertiblePreferredStockMember 2019-12-31 0001778016 imab:SeriesAConvertiblePreferredStockMember 2019-12-31 0001778016 imab:ShareIncentivePlanTwoThousandTwentyMember us-gaap:RestrictedStockMember 2020-09-30 0001778016 imab:TwentyEighteenEmployeeStockOptionPlanMember us-gaap:RestrictedStockMember 2020-09-30 0001778016 imab:SeriesAConvertiblePreferredStockMember 2020-09-30 0001778016 imab:SeriesBConvertiblePreferredStockMember 2020-09-30 0001778016 imab:SeriesCConvertiblePreferredStockMember 2020-09-30 0001778016 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0001778016 us-gaap:RetainedEarningsMember 2020-09-30 0001778016 us-gaap:CommonStockMember 2020-09-30 0001778016 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001778016 us-gaap:ShortTermInvestmentsMember 2020-09-30 0001778016 imab:PutRightLiabilitiesMember 2020-09-30 iso4217:CNY iso4217:USD xbrli:shares xbrli:pure utr:Year utr:Month utr:Day iso4217:USD xbrli:shares iso4217:CNY xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE
13a-16
OR
15d-16
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of
February 2021
Commission File Number:
001-39173
I-MAB
Suite 802, West Tower, OmniVision, 88 Shangke Road, Pudong District
Shanghai, 201210
People’s Republic of China
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F ☒ Form
40-F ☐
Indicate by check mark if the registrant is submitting the Form
6-K
in paper as permitted by Regulation
S-T
Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form
6-K
in paper as permitted by Regulation
S-T
Rule 101(b)(7): ☐

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

I-MAB
By |  | : |  | /s/ Jielun Zhu
Name |  | : |  | Jielun Zhu
Title |  | : |  | Director and Chief Financial Officer

Date: February
5
, 2021

EXHIBIT INDEX

Exhibit No. |  | Description
99.1 |  | Unaudited Consolidated Interim Financial Statements
99.2 |  | Management’s Discussion and Analysis of Financial Condition and Results Of Operations
101.INS |  | Inline XBRL Instance Document – this instance document does not appear in the Interactive Data File because its XBRL tags are not embedded within the Inline XBRL document
101.SCH |  | Inline XBRL Taxonomy Extension Schema
101.CAL |  | Inline XBRL Taxonomy Extension Calculation Linkbase
101.DEF |  | Inline XBRL Taxonomy Extension Definition Linkbase
101.LAB |  | Inline XBRL Taxonomy Extension Label Linkbase
101.PRE |  | Inline XBRL Taxonomy Extension Presentation Linkbase
104 |  | Cover Page Interactive Data File (embedded within the Inline IXBRL document)